Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 372 Records) |
| Query Trace: Adenocarcinoma and BRAF[original query] |
|---|
| Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European journal of cancer (Oxford, England : 1990) 2023 9 193 113310. Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, Chao-Chi Ho, Chia-Lin Hsu, Tzu-Hsiu Tsai, Shang-Gin Wu, Yen-Ting Lin, Wei-Hsun Hsu, Suyog Jain, Steve Olsen, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Ya |
| Promising response of dabrafenib, trametinib, and osimertinib combination therapy for concomitant BRAF and EGFR-TKI resistance mutations. Anti-cancer drugs 2023 8 . Clint Taonaishe Chimbangu, Zhou Ya, Li Xi, Zhao Jiayue, Meng Xiao, Wang Ying, Yu Xingxu, Xiaomei L |
| Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma. Frontiers in oncology 2023 7 13 1169586. Prashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, Richard Huang, Natalie Danziger, Tyler Janovitz, Alina Basnet, Abirami Sivapiragasam, Stephen Graziano, Jeffrey S Ro |
| Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA network open 2023 12 6 (12): e2347700. Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakaga |
| Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| EARLY-ONSET COLORECTAL CANCER: AN ELEVEN-YEAR ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AT A TERTIARY HEALTHCARE CENTER. Arquivos de gastroenterologia 2023 10 60 (3): 315-321. Jean Félix Piñerúa-Gonsálvez, Rosanna Del Carmen Zambrano-Infantino, María Antonella Rizzo-Rodríguez, Aurelio Dueñas-Diez, Luis Fernández-Salaz |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer. Journal of cancer research and clinical oncology 2024 8 150 (8): 394. Mark Uhlenbruch, Stefan Krüg |
| [Gene mutation characteristics of clinical stage ?A lung adenocarcinoma and their relations with patients' long-term prognosis]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 8 46 (8): 755-763. L Zhang, M W Liu, L Li, S Zhao, L L Wu, Z H Yin, M Li, Y N Gao, N |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| KRAS and BRAF genetic alterations in lung cancer: A case - control study. Journal of cancer research and therapeutics 2024 7 20 (3): 782-787. Humaira Aziz Sawal, Syeda Ibtesam Shah, Saima Shakil Malik, Sarmad Mehmood, Mehreen Baig, Ehtsham Rasool, Nosheen Maso |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| [Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 6 53 (6): 578-584. X L Ma, R N Jia, K Han, Y X Zha |
| Genome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposure. Genes and environment : the official journal of the Japanese Environmental Mutagen Society 2024 5 46 (1): 12. Lauri J Sipilä, Riku Katainen, Mervi Aavikko, Janne Ravantti, Iikki Donner, Rainer Lehtonen, Ilmo Leivo, Henrik Wolff, Reetta Holmila, Kirsti Husgafvel-Pursiainen, Lauri A Aalton |
| Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma. Frontiers in oncology 2024 5 14 1389618. Yangui Lin, Dan Li, Hongliang Hui, Haoran Miao, Min Luo, Bhaskar Roy, Binbin Chen, Wei Zhang, Di Shao, Di Ma, Yanbing Jie, Fan Qiu, Huaming Li, Bo Jia |
| Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. Therapeutic advances in medical oncology 2024 5 16 17588359241253113. Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P Thomas, Susan Tsai, Kathleen K Christians, Douglas B Evans, Callisia N Clarke, William A Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamg |
| Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion-insertion R) in an advanced non-small cell lung cancer patient. Thoracic cancer 2024 5 . Akiko Tamura, Ryoko Inaba Higashiyama, Tatsuya Yoshida, Yaya Satozono, Yuichiro O |
| Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report. Oncology letters 2024 5 28 (1): 299. Mingyao Lai, Tianhao Mu, Ming Liu, Qingjun Hu, Juan Li, Tanxiao Huang, Yingmei Li, Shifu Chen, Linbo C |
| Detection of Oncogene Hotspot Mutations in Female NSCLC Tumor DNA and Cell-Free DNA. Cancers 2024 5 16 (9): . Ieva Drejeriene, Saulius Cicenas, Diana Stanciute, Arnoldas Krasauskas, Jurate Gruo |
| Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer. Medicine 2024 4 103 (14): e37693. Weicheng Wang, Rui Wang, Xiao Han, Wei Zhang, Lijun Zhu, Yanhong |
| PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
| Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1. Frontiers in oncology 2024 12 14 1473327. Zachary D Wallen, Mary K Nesline, Marni Tierno, Alison Roos, Erica Schnettler, Hatim Husain, Pratheesh Sathyan, Brian Caveney, Marcia Eisenberg, Eric A Severson, Shakti H Ramkisso |
| Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108038. Aurélie Swalduz, Michèle Beau-Faller, David Planchard, Julien Mazieres, Sophie Bayle-Bleuez, Didier Debieuvre, Vincent Fallet, Margaux Geier, Alexis Cortot, Sébastien Couraud, Catherine Daniel, Charlotte Domblides, Eric Pichon, Elizabeth Fabre, Sébastien Larivé, Ulrike Lerolle, Pascale Tomasini, Marie Wislez, Pascale Missy, Franck Morin, Virginie Westeel, Jean-Bernard Auli |
| Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer. Clinical lung cancer 2024 10 . Alexander S Watson, Harris B Krause, Andrew Elliott, Alex Farrell, Stephen V Liu, Patrick C Ma, Ari VanderWalde, George W Sledge, David Spetzler, Erin L Schenk, D Ross Camid |
| Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics. Frontiers in genetics 2024 10 15 1455502. Lingna Deng, Jinbang Li, Zhanlong Qiu, Yanfen Wa |
| Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN). Genes, chromosomes & cancer 2024 10 63 (10): e23270. Julia Doll, Katja Maurus, Franziska Köhler, Niels Matthes, Johan F Lock, Christoph-Thomas Germer, Andreas Rosenwald, Armin Wiegeri |
| Colorectal Cancer Brain Metastasis With Concomitant KRAS and BRAF Mutations: A Case Report. Cureus 2024 10 16 (9): e68975. Alexandra Vesa, Octavian Maghiar, Ottó Molnar, Ovidiu Pop, Adrian Maghi |
| Colorectal Cancer: A Brief and Simplified Analysis of a Complex Disease. Medicina (Kaunas, Lithuania) 2025 1 60 (12): . Krasimir Petrov, Ivan Ivanov, Savelina Popovska, Tatyana Betova, Zornitsa Kamburo |
- Page last reviewed:Feb 1, 2024
- Content source: